Victor Olmos

Victor Olmos is an Investment Associate at Kendall Capital Partners, where he focuses on advancing cures for rare neurodegenerative diseases through early-stage venture capital investments. He began his academic career conducting foundational stem cell research during his undergraduate studies at Stanford University before earning a PhD from Yale University. During his doctoral training at Yale, his research specifically targeted the underlying mechanisms of rare neurodegenerative conditions. Driven by a personal family history with Huntington’s disease, Olmos transitioned from academic science to biotechnology investing to accelerate the discovery and commercialization of novel therapeutic treatments. His approach to evaluating innovative research is heavily informed by his immigrant family roots, which instilled a strong foundation of perseverance. Olmos currently leverages his deep scientific expertise to identify and support emerging biotech ventures dedicated to solving complex medical challenges.